ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is defined as a highly aggressive subtype of breast cancer, which lacks estrogen receptor (ER), progesterone receptor (PR) expression, and no amplification of human epidermal growth factor receptor 2 (HER2) [1].